Background: We hypothesized that acarbose would delay conversion from impaired glucose tolerance (IGT) to type 2 diabetes by alleviating postprandial hyperglycaemia. Our study's main objective was to investigate the effect of acarbose in IGT-persons on their 2-h plasma glucose level and beta-cell function. Subjects and Methods: The study included a random sample of 45-70-year-old residents of Hoorn, Netherlands, with mean fasting plasma glucose <7.8 mmol/L and mean 2-h plasma glucose of 8.6-11.1 mmol/L (measured by two successive oral glucose tolerance tests). After a qualification period, participants were randomized to acarbose treatment or placebo. Insulin secretion and insulin sensitivity were measured by hyperglycaemic clamp. After a 3...
none6AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patien...
OBJECTIVE: To assess the efficacy, safety and extent of perceived indications of acarbose, a new ant...
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands. jse@sin...
OBJECTIVE: To determine the degree to which alpha-glucosidase inhibitors, with their unique mode of ...
This multicentre, double-blind, placebo-controlled study investigated the efficacy of acarbose in Ch...
Background: This study assessed the effect of postprandial glucose reduction by acarbose on insulin ...
Contains fulltext : 50590.pdf (publisher's version ) (Open Access)BACKGROUND: Alph...
PubMed ID: 10728163Objective: Acarbose, a potent alpha-glucosidase inhibitor, provides a new Concept...
<p>Aim. To evaluate postprandial changes of lipid and glucose profiles, inflammation markers levels ...
Acarbose, an alpha-glucosidase inhibitor, is a new antihyperglycaemic agent which has been proposed ...
BACKGROUND: Alpha-glucosidase inhibitors (AGIs) reduce blood glucose levels and may thus prevent typ...
Objective: To investigate the efficacy and tolerability of the anti-diabetic agent acarbose (Glucoba...
AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patients be...
AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patients be...
OBJECTIVE- To determine the efficacy of acarbose, compared with placebo, on the metabolic control of...
none6AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patien...
OBJECTIVE: To assess the efficacy, safety and extent of perceived indications of acarbose, a new ant...
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands. jse@sin...
OBJECTIVE: To determine the degree to which alpha-glucosidase inhibitors, with their unique mode of ...
This multicentre, double-blind, placebo-controlled study investigated the efficacy of acarbose in Ch...
Background: This study assessed the effect of postprandial glucose reduction by acarbose on insulin ...
Contains fulltext : 50590.pdf (publisher's version ) (Open Access)BACKGROUND: Alph...
PubMed ID: 10728163Objective: Acarbose, a potent alpha-glucosidase inhibitor, provides a new Concept...
<p>Aim. To evaluate postprandial changes of lipid and glucose profiles, inflammation markers levels ...
Acarbose, an alpha-glucosidase inhibitor, is a new antihyperglycaemic agent which has been proposed ...
BACKGROUND: Alpha-glucosidase inhibitors (AGIs) reduce blood glucose levels and may thus prevent typ...
Objective: To investigate the efficacy and tolerability of the anti-diabetic agent acarbose (Glucoba...
AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patients be...
AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patients be...
OBJECTIVE- To determine the efficacy of acarbose, compared with placebo, on the metabolic control of...
none6AIM: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patien...
OBJECTIVE: To assess the efficacy, safety and extent of perceived indications of acarbose, a new ant...
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands. jse@sin...